Effects of Warm-up Intensity & Blood Flow Restriction

Status Recruiting

Clinical Trial Summary

Introduction: warming up has the function of preparing the body structures for a given task to be performed during sports, increasing body and muscle temperature, focusing on improving performance. Therefore, the use of the blood flow restriction technique (BFR) can be seen as a promising alternative for promoting greater mechanical and muscular stress, thus providing a more efficient warm-up and optimizing performance. Objectives: to analyze the effects of RFS used during low-intensity warm-up compared with low-intensity and high-intensity warm-up without RFS on performance (jump test and 30-meter sprint test) and skin surface temperature. In addition to analyzing and comparing, after the warm-up protocols with and without RFS, the acute responses on perceptual outcomes (perception of pain, change in sensitivity, subjective perception of exertion and perception of discomfort in relation to RFS) and muscle outcomes (tonus , muscle stiffness and elasticity). Methods: a randomized controlled clinical trial will be carried out, with 33 amateur soccer players aged between 18 and 35 years who will be randomly divided into three groups: low-intensity warm-up without RFS (30% VO2max), high-intensity warm-up without RFS ( 80% VO2max) and low-intensity warm-up associated with BFR (80% of total occlusion pressure) [30% VO2max-BFR]. All groups will carry out the heating protocol and the outcomes will be evaluated at baseline and immediately after the end of the heating, as well as 10 and 20 minutes after its completion, namely: skin surface temperature through thermography; tone, stiffness and muscle elasticity by myotometry, subjective perception of pain (VAS); pain threshold through the pressure algometer; subjective perception of exertion (BORG scale); perception of discomfort in relation to RFS (LIKERT-CR-10 scale); 30-meter sprints measured through photocells and vertical jump, measured through the force platform. Descriptive statistics will be used and comparisons will be made using the generalized linear mixed model, assuming a significance level of p<0.05.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Healthy Men

Clinical Trial Details

NCT number	NCT05523674
Study type	Interventional
Source	Paulista University
Contact
Status	Recruiting
Phase	N/A
Start date	March 15, 2024
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02575209` - Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects	N/A
Completed	`NCT00900107` - Time-Dependent Mobilization of Circulating Progenitor Cells During Strenuous Exercise in Healthy Individuals	N/A
Completed	`NCT02517775` - Effects of Cranberry Consumption in Vascular Function in Healthy Individuals	N/A
Active, not recruiting	`NCT03298373` - 28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men	Phase 1
Completed	`NCT03339167` - Metabolic Availability of Lysine From Millet in Adult Men	N/A
Completed	`NCT01710280` - Palmitic Acid in the Sn-2 Position of Triacylglycerols and Postprandial Lipemia	N/A
Completed	`NCT01130948` - Sleep, Breathing and Psychomotor Performance at Altitude: A Physiologic Study in Healthy Subjects	N/A
Completed	`NCT01382069` - Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men	Phase 1
Not yet recruiting	`NCT05865574` - A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection	Phase 1
Completed	`NCT01296997` - Calcium Phosphate and Incretins	N/A
Completed	`NCT01293591` - Garlic Intake And Biomarkers Of Cancer Risk	N/A
Completed	`NCT00935662` - A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses	Phase 1
Completed	`NCT01221558` - Effects of Lycopene on Oxidative Stress and Markers of Endothelial Function Healthy Men	Phase 3
Active, not recruiting	`NCT05825781` - Study, Evaluating Pharmacokinetics, Immunogenicity and Safety Profiles of Pertuzumab Compared to Perjeta® in Healthy Man	Phase 1
Completed	`NCT02994602` - Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males	Phase 1
Completed	`NCT02365987` - The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Lipaemia and Satiety	N/A
Completed	`NCT02072278` - Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects	Phase 1
Completed	`NCT02093169` - D2 Dopamine Receptor Occupancy After Oral Dosing of Lu AF35700 in Healthy Men Using [11C]-PHNO as Tracer Compound	Phase 1
Completed	`NCT03411005` - Metabolic Availability of Lysine From Sorghum in Adult Men	N/A
Recruiting	`NCT02927210` - Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Warm-up Intensity and Blood Flow Restriction

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms